Laboratory Characteristics in Chronic Atrophic Acrodermatitis

• Status: Unknown status
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with chronic atrophic dermatitis to gain better insight into pathogenesis of chronic infection with Borrelia burgdorferi sensu lato.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Medical Centre Ljubljana
• Collaborators: Harvard University; Medical University of Vienna; University of Ljubljana School of Medicine, Slovenia
• Treatments: Doxycycline

Criteria

Inclusion Criteria:

• chronic atrophic dermatitis in patients >18 years

Exclusion Criteria:

• none